These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 6206096

  • 1. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.
    Mackie IJ, Jones R, Machin SJ.
    J Clin Pathol; 1984 Aug; 37(8):874-8. PubMed ID: 6206096
    [Abstract] [Full Text] [Related]

  • 2. Effect of Iloprost (ZK 36 374), a novel prostacyclin analogue, on ADP-induced platelet aggregation.
    Wadenvik H, Kutti J.
    Acta Haematol; 1985 Aug; 73(4):224-7. PubMed ID: 2414956
    [Abstract] [Full Text] [Related]

  • 3. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR, Belch JJ, Lowe GD, Barbenel JC, Forbes CD.
    Haemostasis; 1987 Aug; 17(3):147-53. PubMed ID: 2440771
    [Abstract] [Full Text] [Related]

  • 4. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR, Lowe GD, Belch JJ, Forbes CD, Prentice CR, Barbenel JC.
    Thromb Haemost; 1983 Oct 31; 50(3):718-21. PubMed ID: 6196854
    [Abstract] [Full Text] [Related]

  • 5. Effects of prostacyclin and of the stable prostacyclin analogue ZK 36374 on forearm blood flow and blood platelet behaviour in man.
    Cowley AJ, Heptinstall S, Hampton JR.
    Thromb Haemost; 1985 Feb 18; 53(1):90-4. PubMed ID: 2581332
    [Abstract] [Full Text] [Related]

  • 6. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG, Wong T, Frojmovic MM.
    Thromb Haemost; 1988 Apr 08; 59(2):323-8. PubMed ID: 2455359
    [Abstract] [Full Text] [Related]

  • 7. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR, Lowe GD, Belch JJ, Barbenel JC, Forbes CD.
    Haemostasis; 1984 Apr 08; 14(6):487-94. PubMed ID: 6442909
    [Abstract] [Full Text] [Related]

  • 8. Platelet function studies during and after infusions of ZK 36374, a stable prostacyclin analogue, to healthy volunteers.
    Yardumian DA, Mackie IJ, Brennan EC, Bull H, Machin SJ.
    Haemostasis; 1986 Apr 08; 16(1):20-6. PubMed ID: 2422095
    [Abstract] [Full Text] [Related]

  • 9. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P, Colli S, Sirtori C, Tremoli E, Paoletti R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Apr 08; 13():363-9. PubMed ID: 2408447
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of platelet aggregation in whole blood by adrenoceptor antagonists.
    Greer IA, Walker JJ, Calder AA, Forbes CD.
    Thromb Res; 1985 Dec 01; 40(5):631-43. PubMed ID: 3937284
    [Abstract] [Full Text] [Related]

  • 11. Critical evaluation of platelet aggregation in whole human blood.
    Riess H, Braun G, Brehm G, Hiller E.
    Am J Clin Pathol; 1986 Jan 01; 85(1):50-6. PubMed ID: 3079628
    [Abstract] [Full Text] [Related]

  • 12. A chemically stable analogue, 9 beta-methyl carbacyclin, with similar effects to epoprostenol (prostacyclin, PGI2) in man.
    O'Grady J, Hedges A, Whittle BJ, Al-Sinawi LA, Mekki QA, Burke C, Moody SG, Moti MJ, Hassan S.
    Br J Clin Pharmacol; 1984 Dec 01; 18(6):921-33. PubMed ID: 6085004
    [Abstract] [Full Text] [Related]

  • 13. Interactions between prostacyclin analogue ZK 36374 and heparin in their effects upon platelet function.
    Yardumian DA, O'Flynn K, Linch DC, Machin SJ.
    Br J Haematol; 1987 Mar 01; 65(3):325-30. PubMed ID: 2436647
    [Abstract] [Full Text] [Related]

  • 14. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N.
    Arzneimittelforschung; 1986 Aug 01; 36(8):1180-3. PubMed ID: 3096342
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA, Walker JJ, McLaren M, Calder AA, Forbes CD.
    Thromb Res; 1986 Feb 15; 41(4):509-18. PubMed ID: 3083526
    [Abstract] [Full Text] [Related]

  • 16. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W, Roth P, Weber PC.
    Thromb Haemost; 1981 Jun 30; 45(3):204-7. PubMed ID: 7025338
    [Abstract] [Full Text] [Related]

  • 17. Platelet sensitivity in vitro to the prostacyclin analogue iloprost in diabetic patients.
    Vicari AM, Macagni A, Pozza G.
    Horm Metab Res; 1989 Nov 30; 21(11):616-8. PubMed ID: 2480323
    [Abstract] [Full Text] [Related]

  • 18. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter.
    Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JR.
    Thromb Haemost; 1982 Dec 27; 48(3):327-9. PubMed ID: 6819649
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374.
    Adaikan PG, Karim SM, Lau LC, Tai MY, Kottegoda SR.
    Thromb Res; 1984 Feb 01; 33(3):333-40. PubMed ID: 6200948
    [Abstract] [Full Text] [Related]

  • 20. Effects of plasma on the platelet antiaggregatory action of prostacyclin in pregnancy.
    Baker VV, Kort B, Cefalo RC.
    Am J Obstet Gynecol; 1987 Apr 01; 156(4):974-7. PubMed ID: 3107390
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.